|
Test Catalog
|
| Type of Disorder: |
Neuromuscular Disorders |
|
| Typical Presentation: |
Individuals with a range of symptoms from cataracts to significant muscle wasting, cardiac complications, ptosis and myotonia |
|
| Disease(s) tested for: |
Myotonic dystrophy, Type 2 |
|
| Test Details |
|
| Test Code: |
110 |
|
| Profiles that contain this test: |
Complete Myotonia Evaluation, Complete Myotonic Dystrophy Evaluation
|
|
| Informed Consent Required: |
Yes |
|
| Medicare ABN Required: |
Yes |
|
| Special Notes: |
Unless a family member has been confirmed by prior testing, it is recommended that this test be done as part of the Complete Myotonic Dystrophy Evaluation, #126. |
|
| Technical Information |
|
| Utility: |
Detects CCTG repeat expansions in the Zinc Finger Protein 9 (ZNF9) gene |
|
| Methodology: |
Polymerase Chain Reaction (PCR), Fragment analysis and Southern blot |
|
| Reference Value: |
Normal: Less than 177 base pairs |
|
| CPT Code(s): |
83891(1), 83898(1), 83909(1), 83912(1) |
|
| Patents: |
6,902,896 |
|
| Shipping Considerations |
|
| Preferred Specimen Requirements |
| Type: |
Whole blood |
| Minimum Volume: |
20ml |
| Collection Tube: |
Lavender top (EDTA) |
|
| Storage Conditions: |
Room temperature, avoid freezing |
|
| Shipping Conditions: |
Room temperature, avoid freezing. Ship same day, must arrive Monday - Friday. |
|
| Test Turnaround: |
21-28 days |
|
|
|
